XM does not provide services to residents of the United States of America.

Wall Street dips with focus on tariffs, economic data



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall Street dips with focus on tariffs, economic data</title></head><body>

Novavax drops on cut to annual revenue forecast

Honeywell jumps after Elliott discloses stake

Russell 2000 falls more than 1%

Indexes down: Dow 0.52%, S&P 500 0.10%, Nasdaq 0.02%

Updated prices at 2:31 p.m ET/ 1931 GMT

By Sinéad Carew and Lisa Pauline Mattackal

Nov 12 (Reuters) -Wall Street's main indexes fell on Tuesday as investors booked profits from post-election gains and awaited U.S. inflation data due in the coming days.

The three major indexes had rallied to record highs since the Nov. 5 U.S. election as investors bet on a boost to equities from President-elect Donald Trump's proposed tax cuts and the prospect of easier regulatory policies.

But investor enthusiasm was dampened on Tuesday. European shares lost 2% as European Central Bank policymakers warned that increased tariffs from Trump would hamper global growth.

Some of the stocks expected to perform well under Trump gave back gains. Shares in electric car maker Tesla TSLA.O were down close to 5% after rising nearly 40% since the election results.

The small-cap Russell 2000 index .RUT fell 1.5% after closing at a three-year high on Monday.

Russell Price, chief economist at Ameriprise Financial, said the decline in stocks overseas pressured U.S. stocks, along with profit-taking after the rally and ahead of inflation data.

"When we opened up already experiencing some downside with the very strong run that we've had, investors tend to look to take some profits just in case stocks continue to slide," Price said.

On investors' radar is Wednesday's consumer price inflation data, followed by producer prices inflation and retail sales data this week, that are expected to provide clues about the U.S. Federal Reserve's policy path going forward.

The data presents a near-term risk to investments, said Price. "It very likely is contributing to a little bit of the downside that we're seeing today."

At 2:31 p.m., the Dow Jones Industrial Average .DJI fell 230.63 points, or 0.52%, to 44,062.50, the S&P 500 .SPX lost 6.20 points, or 0.10%, to 5,995.15 and the Nasdaq Composite .IXIC lost 3.25 points, or 0.02%, to 19,295.51.

Among the S&P 500's 11 major industry sectors, materials .SPLRCM and utilities .SPLRCU led declines with more than 1% losses while consumer staples .SPLRCS was among the biggest gainers.

Markets have already dialed back expectations for interest-rate reductions over the next year, given strong economic data and the possible inflationary impact of some Trump policies.

Richmond Fed President Thomas Barkin said on Tuesday that the U.S. central bank is ready to respond if inflation pressures rise or the job market weakens.

The blue-chip Dow was weighed down by declines in healthcare and financial stocks, including UnitedHealth UNH.N and Goldman Sachs GS.N, both off around 1%.

Biotech firm Novavax NVAX.O dropped 5.8% after cutting its annual revenue forecast due to lower-than-expected sales of its COVID-19 vaccine.

Honeywell HON.O hit a record high and was last up 3% after activist investor Elliott Investment said it has built a stake worth more than $5 billion in the industrial conglomerate.

Declining issues outnumbered advancers by a 3.25-to-1 ratio on the New York Stock Exchange where there were 281 new highs and 91 new lows.

On the Nasdaq, 1,350 stocks rose and 2,885 fell as declining issues outnumbered advancers by a 2.14-to-1 ratio. The S&P 500 posted 51 new 52-week highs and 15 new lows while the Nasdaq Composite recorded 177 new highs and 109 new lows.



Reporting by Sinéad Carew in New York, Lisa Mattackal and Purvi Agarwal in Bengaluru; Editing by Shounak Dasgupta and Rod Nickel

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.